CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Heska Corporation Company Snapshot
Heska Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Heska with three other companies in this sector in the United States: Denali Therapeutics Inc (2018 sales of $129.16 million of which 100% was Pharmacetical), Nanostring Technologies Inc ($106.73 million of which 100% was Research and Diagnostic Testing), and Halozyme Therapeutics, Inc. ($151.86 million of which 100% was Biopharmaceutical).

Sales Analysis. Heska reported sales of $127.45 million for the year ending December of 2018. This represents a decrease of 1.5% versus 2017, when the company's sales were $129.34 million. Contributing to the drop in overall sales was the 23.3% decline in Other Vaccines, Pharmaceuticals and Produc, from $24.15 million to $18.52 million. . However, these declines were partially offset by the increase in sales of Core Companion Animal Health (up 3.5% to $108.92 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Heska Corporation
  Stock Performance Chart for Heska Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 72.94
(Figures in U.S. Dollars)
1 Week -2.0%   13 Weeks -9.1%  
4 Weeks -6.6%   52 Weeks -27.4%  
 
Heska Corporation Key Data:
  Ticker: HSKA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 127,446,000
(Year Ending Jan 2019).
Employees: 347
  Currency: U.S. Dollars Market Cap: 568,514,127
  Fiscal Yr Ends: December Shares Outstanding: 7,794,271
  Share Type: Common Closely Held Shares: 932,509
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.